These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9192790)

  • 1. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes.
    Cohen JL; Boyer O; Salomon B; Onclercq R; Charlotte F; Bruel S; Boisserie G; Klatzmann D
    Blood; 1997 Jun; 89(12):4636-45. PubMed ID: 9192790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.
    Drobyski WR; Morse HC; Burns WH; Casper JT; Sandford G
    Blood; 2001 Apr; 97(8):2506-13. PubMed ID: 11290616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene.
    Thomas-Vaslin V; Bellier B; Cohen JL; Boyer O; Raynal-Raschilas N; Glotz D; Klatzmann D
    Transplantation; 2000 May; 69(10):2154-61. PubMed ID: 10852616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
    Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
    J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene.
    Drobyski WR; Gendelman M
    Leuk Lymphoma; 2002 Oct; 43(10):2011-6. PubMed ID: 12481900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction?
    Gallot G; Hallet MM; Gaschet J; Moreau JF; Vivien R; Bonneville M; Milpied N; Vié H
    Blood; 1996 Aug; 88(3):1098-103. PubMed ID: 8704220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting.
    Contassot E; Ferrand C; Angonin R; Cohen JL; de Carvalho Bittencourt M; Lorchel F; Laithier V; Cahn JY; Klatzmann D; Herve P; Tiberghien P
    Transplantation; 2000 Feb; 69(4):503-8. PubMed ID: 10708102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
    Tiberghien P; Ferrand C; Lioure B; Milpied N; Angonin R; Deconinck E; Certoux JM; Robinet E; Saas P; Petracca B; Juttner C; Reynolds CW; Longo DL; Hervé P; Cahn JY
    Blood; 2001 Jan; 97(1):63-72. PubMed ID: 11133743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene.
    Helene M; Lake-Bullock V; Bryson JS; Jennings CD; Kaplan AM
    J Immunol; 1997 Jun; 158(11):5079-82. PubMed ID: 9164920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological defects after suicide gene therapy of experimental graft-versus-host disease.
    Cohen JL; Lacroix-Desmazes S; Charlotte F; Lejeune L; Martin PJ; Klatzmann D; Boyer O
    Hum Gene Ther; 1999 Nov; 10(16):2701-7. PubMed ID: 10566898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide gene-mediated modulation of graft-versus-host disease.
    Cohen JL; Boyer O; Thomas-Vaslin V; Klatzmann D
    Leuk Lymphoma; 1999 Aug; 34(5-6):473-80. PubMed ID: 10492070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
    Munshi NC; Govindarajan R; Drake R; Ding LM; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
    Blood; 1997 Feb; 89(4):1334-40. PubMed ID: 9028956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
    Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
    Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
    Tiberghien P; Reynolds CW; Keller J; Spence S; Deschaseaux M; Certoux JM; Contassot E; Murphy WJ; Lyons R; Chiang Y
    Blood; 1994 Aug; 84(4):1333-41. PubMed ID: 8049449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.
    Weijtens M; van Spronsen A; Hagenbeek A; Braakman E; Martens A
    Hum Gene Ther; 2002 Jan; 13(2):187-98. PubMed ID: 11812276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would suicide gene therapy solve the 'T-cell dilemma' of allogeneic bone marrow transplantation?
    Cohen JL; Boyer O; Klatzmann D
    Immunol Today; 1999 Apr; 20(4):172-6. PubMed ID: 10203714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.